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Data collection and refinement statistics for the substrate-bound DnaK-SBD X-ray structure (residues 389-607, PDB code 4F01) 2 . We also generated three independent unliganded DnaK-SBD X-ray structures (referred to here as DnaK-SBD-A, DnaK-SBD-B and DnaK-SBD-C), which were refined to 2.36 Å, 1.75 Å and 2.97 Å (Supplementary Table S2 ). These structures were compared to the DnaK-PET-16 structure. As shown, the The DnaK-PET-16 structure also displays several conformational differences relative to the reported unliganded DnaK-SBDβ, particularly in the loops of SBDβ and along strands β3, β7
and β8 (Supplementary Figure S4C) . Notably, in the surface diagrams, the PET-16-binding cavity is not available in the DnaK-SBDβ structure (Supplementary Figure S4C) Table S4 ). The overall fold of the SBDβ of our DnaK-NRLLLTG-A is virtually identical to the reported DnaK-NRLLLTG structure (PDB code 1DKZ), with a rmsd of 0.28 Å (Supplementary Table S3 ). However, the SBDβ domains of which is a bromine salt, is soluble to 100 mM in water and 1X DPBS. The protein mixtures were preheated to 42°C for 15 minutes and gradually cooled to room temperature (referred to here as the heat shock method). We chose the heat shock method, because we only obtained cocrystals of DnaK-PET-16 using this approach. In this report, we also generated four additional control crystals using the heat shock method: DnaK-SBD-A, DnaK-SBD-B, DnaK-SBD-C and DnaK-NRLLLTG-A. These unliganded and peptide-bound structures were refined to 2.36 Å, model building was performed using the program COOT. 7 The PET-16 and NRLLLTG ligands were modeled into the corresponding electron density maps after refinement of the protein had converged. Note, the density assigned to the small molecule inhibitor PET-16 is not an alternative linker conformation; the linker density is well defined in the DnaK-PET-16 structure, even at very low contour. The final model, and the modeled PET-16 inhibitor, was checked for errors with a composite omit map generated by AutoBuild in the Phenix suite. 8 Data collection
and refinement statistics are shown in Supplementary Tables S1, S2 and S4. All the structural figures were prepared using PYMOL (http://www.pymol.org/). 9 Note, the observed PET-16
interacting pocket in the DnaK-PET-16 structure is also visible in the DnaK-NRLLLTG structures (PDB codes 1DKZ and 1DKY) 3 and the HSP70-NRLLLTG structure (PDB code 4PO2) 10 . 
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Our ITC results contrast with a recently published report that failed to detect a specific interaction between PES and the full-length HSP70 protein using ITC. 18 We attribute this discrepancy to the disparate experimental conditions employed, including buffer conditions and how the ITC titrations are set up. For instance, Schlecht et al. 18 performed all titration by injecting PES pre-mixed with ADP (final DMSO concentration of 1%) into the calorimeter chamber containing the full-length ADP-bound HSP70 protein (final DMSO concentration of 1%). We found that only when ADP-bound HSP70 was titrated into the calorimeter chamber containing the PES solution (final DMSO concentration of 3%) was an interaction robust and readily detectable; this may reflect the poor solubility of the PES reagent. In contrast, we found that the interaction was impaired when the PES solution was injected into the sample cell containing the recombinant protein, as was done previously. 18 We also failed to detect any interaction between HSP70 and PES, when ADP was added to both the calorimeter chamber and titration syringe, as was done in the previous work. 18 Moreover, the buffer that we used for the ITC analysis does not contain any reducing agent, which can inactivate PES. Thus, by testing several different parameters, and optimizing the ITC protocol conditions, we are readily able to detect a direct, specific interaction between the small molecules and HSP70 as well as between our inhibitors and DnaK. Our finding that PES preferentially targets a "non-ATPbound" form of HSP70 is consistent with a previous observation that PES inhibits a "non-ATP dependent" form of HSP70 involved in the activation of apo-neuronal nitric oxide synthase. 
